Ypsomed Holding AG
YPSN.SW
Exchange: | SW |
Currency | Swiss Franc |
Open Figi: | BBG000BTC786 |
ISIN: | CH0019396990 |
LEI: | 391200QLIOTTBNPNSI14 |
Primary Ticker: | YPSN.SW |
Fiscal Year End: | March |
Sector: | Healthcare |
Industry: | Medical Instruments & Supplies |
Gic Sector: | Health Care |
Gic Group: | Health Care Equipment & Services |
Gic Industry: | Health Care Equipment & Supplies |
Gic Sub Industry: | Health Care Equipment |
Description: | Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. |
Address: | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 |
Website: | https://www.ypsomed.com |
Full Time Employees: | 2296 |
Updated On: | 2024-11-05 |
Highlights
Market Capitalization: | 5364332032 |
Market Capitalization Mln: | 5364.33 |
EBITDA: | 132685000 |
PE Ratio: | 68.58 |
Wall Street Target Price: | 177.5 |
Book Value: | 45.25 |
Dividend Share: | 2 |
Earnings Share: | 5.73 |
EPS Estimate Current Year: | 2.84 |
EPS Estimate Next Year: | 5.29 |
Most Recent Quarter: | 2024-03-31 |
Profit Margin: | 0.14 |
Operating Margin TTM: | 0.15 |
Return On Assets TTM: | 0.05 |
Return On Equity TTM: | 0.13 |
Revenue TTM: | 548457024 |
Revenue Per Share TTM: | 40.18 |
Quarterly Revenue Growth YOY: | 0.15 |
Gross Profit TTM: | 113817000 |
Diluted Eps TTM: | 5.73 |
Quarterly Earnings Growth YOY: | 0.16 |
Valuation
Trailing PE: | 68.58 |
Forward PE: | 31.54 |
Price Sales TTM: | 9.78 |
Price Book MRQ: | 8.73 |
Enterprise Value: | 5580454774 |
Enterprise Value Revenue: | 10.17 |
Enterprise Value Ebitda: | 34.54 |
Shares
Shares Outstanding: | 13649700 |
Shares Float: | 3819606 |
Percent Insiders: | 71.94 |
Percent Institutions: | 12.87 |
Technicals
Beta: | 0.97 |
52 Week High: | 439 |
52 Week Low: | 254.86 |
50 Day MA: | 413.14 |
200 Day MA: | 382.10 |
Splits & Dividends
Forward Annual Dividend Rate: | 2 |
Payout Ratio: | 0.33 |
Dividend Date: | 2024-07-03 |
Ex Dividend Date: | 2024-07-01 |
Last Split Factor: | 1629:1624 |
Last Split Date: | 2022-06-16 |
Earnings
Report Date: | 2024-11-13 |
Date: | 2024-09-30 |
Before After Market: | After Market |
Currency: | CHF |
Report Date: | 2023-05-24 |
Date: | 2023-03-31 |
Before After Market: | After Market |
Currency: | CHF |
Eps Actual: | 2.63 |
Report Date: | 2022-11-16 |
Date: | 2022-09-30 |
Before After Market: | After Market |
Currency: | CHF |
Eps Actual: | 1.17 |
Report Date: | 2022-05-25 |
Date: | 2022-03-31 |
Before After Market: | Before Market |
Currency: | CHF |
Eps Actual: | 1.26 |
Eps Difference: | 1.26 |
Report Date: | 2021-11-04 |
Date: | 2021-09-30 |
Before After Market: | Before Market |
Currency: | CHF |
Eps Actual: | 0.56 |
Eps Difference: | 0.56 |
Report Date: | 2021-05-27 |
Date: | 2021-03-31 |
Currency: | CHF |
Eps Actual: | -0.06 |
Eps Difference: | -0.06 |
Report Date: | 2020-11-03 |
Date: | 2020-09-30 |
Currency: | CHF |
Eps Actual: | 0.52 |
Eps Difference: | 0.52 |
Report Date: | 2020-05-27 |
Date: | 2020-03-31 |
Currency: | CHF |
Eps Actual: | 0.31 |
Eps Difference: | 0.31 |
Report Date: | 2019-11-06 |
Date: | 2019-09-30 |
Currency: | CHF |
Eps Actual: | 0.6 |
Eps Difference: | 0.6 |
Report Date: | 2019-05-23 |
Date: | 2019-03-31 |
Currency: | CHF |
Eps Actual: | 0.32 |
Eps Difference: | 0.32 |
Report Date: | 2018-11-06 |
Date: | 2018-09-30 |
Currency: | CHF |
Eps Actual: | 4.45 |
Eps Difference: | 4.45 |
Report Date: | 2018-05-25 |
Date: | 2018-03-31 |
Currency: | CHF |
Eps Actual: | 2.28 |
Eps Difference: | 2.28 |
Report Date: | 2017-11-10 |
Date: | 2017-09-30 |
Currency: | CHF |
Eps Actual: | 1.86 |
Eps Difference: | 1.86 |
Report Date: | 2017-06-14 |
Date: | 2017-03-31 |
Currency: | CHF |
Eps Actual: | 1.89 |
Eps Difference: | 1.89 |
Report Date: | 2016-11-24 |
Date: | 2016-09-30 |
Currency: | CHF |
Eps Actual: | 1.78 |
Eps Difference: | 1.78 |
Report Date: | 2016-05-20 |
Date: | 2016-03-31 |
Currency: | CHF |
Eps Actual: | 1.63 |
Eps Difference: | 1.63 |
Date: | 2024-03-31 |
Period: | +1y |
Growth: | 0.86 |
Earnings Estimate Avg: | 5.29 |
Earnings Estimate Low: | 4.68 |
Earnings Estimate High: | 5.67 |
Earnings Estimate Year Ago Eps: | 2.84 |
Earnings Estimate Number Of Analysts: | 3.00 |
Earnings Estimate Growth: | 0.86 |
Revenue Estimate Avg: | 638070000.00 |
Revenue Estimate Low: | 585490000.00 |
Revenue Estimate High: | 715820000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.13 |
Eps Trend Current: | 5.29 |
Eps Trend7days Ago: | 5.29 |
Eps Trend30days Ago: | 5.23 |
Eps Trend60days Ago: | 5.09 |
Eps Trend90days Ago: | 5.09 |
Eps Revisions Up Last30days: | 1.00 |
Date: | 2023-06-30 |
Period: | +1q |
Date: | 2023-03-31 |
Growth: | 0.55 |
Earnings Estimate Avg: | 2.84 |
Earnings Estimate Low: | 2.57 |
Earnings Estimate High: | 3.18 |
Earnings Estimate Year Ago Eps: | 1.83 |
Earnings Estimate Number Of Analysts: | 3.00 |
Earnings Estimate Growth: | 0.55 |
Revenue Estimate Avg: | 562560000.00 |
Revenue Estimate Low: | 520030000.00 |
Revenue Estimate High: | 642740000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.21 |
Eps Trend Current: | 2.84 |
Eps Trend7days Ago: | 2.84 |
Eps Trend30days Ago: | 2.79 |
Eps Trend60days Ago: | 3.88 |
Eps Trend90days Ago: | 3.88 |
Eps Revisions Up Last30days: | 1.00 |
Date: | 2022-12-31 |
Period: | +1q |
Date: | 2022-09-30 |
Date: | 2022-06-30 |
Period: | +1q |
Date: | 2022-03-31 |
Revenue Estimate Avg: | 528890000.00 |
Revenue Estimate Low: | 520030000.00 |
Revenue Estimate High: | 543400000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.13 |
Date: | 2020-03-31 |
Period: | +1y |
Revenue Estimate Avg: | 405500000.00 |
Revenue Estimate Low: | 362000000.00 |
Revenue Estimate High: | 432430000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | -0.05 |
Eps Trend7days Ago: | 2.22 |
Eps Trend30days Ago: | 2.22 |
Eps Trend60days Ago: | 2.22 |
Eps Trend90days Ago: | 2.22 |
Date: | 2019-09-30 |
Period: | +1q |
Revenue Estimate Avg: | 429900000.00 |
Revenue Estimate Low: | 378000000.00 |
Revenue Estimate High: | 459340000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | -0.07 |
Date: | 2019-06-30 |
Revenue Estimate Avg: | 429900000.00 |
Revenue Estimate Low: | 378000000.00 |
Revenue Estimate High: | 459340000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | -0.07 |
Date: | 2019-03-31 |
Revenue Estimate Avg: | 429900000.00 |
Revenue Estimate Low: | 378000000.00 |
Revenue Estimate High: | 459340000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | -0.07 |
Eps Trend7days Ago: | 4.75 |
Eps Trend30days Ago: | 4.75 |
Eps Trend60days Ago: | 4.75 |
Eps Trend90days Ago: | 4.75 |
Date: | 2024-09-30 |
Date: | 2023-03-31 |
Eps Actual: | 3. |
Date: | 2022-03-31 |
Eps Actual: | 1.8 |
Date: | 2021-03-31 |
Eps Actual: | 0.4 |
Date: | 2020-03-31 |
Eps Actual: | 0.9 |
Date: | 2019-03-31 |
Eps Actual: | 4.7 |
Date: | 2018-03-31 |
Eps Actual: | 4.1 |
Date: | 2017-03-31 |
Eps Actual: | 3.6 |
Date: | 2016-03-31 |
Eps Actual: | 1.6 |